Podchaser Logo
Home
105. MDMA medicalisation in the US with Dr Julie Holland

105. MDMA medicalisation in the US with Dr Julie Holland

Released Wednesday, 5th June 2024
Good episode? Give it some love!
105. MDMA medicalisation in the US with Dr Julie Holland

105. MDMA medicalisation in the US with Dr Julie Holland

105. MDMA medicalisation in the US with Dr Julie Holland

105. MDMA medicalisation in the US with Dr Julie Holland

Wednesday, 5th June 2024
Good episode? Give it some love!
Rate Episode

In this episode we meet with Dr Julie Holland. 

She discussed how MDMA influenced her career and inspired her to investigate its therapeutic potential. Controversially, she has investigated the effect of MDMA in schizophrenia and its potential in preventing paranoia and inhibiting auditory hallucinations during its effects. 

Dr Holland touches upon debate subjects such as the likelihood of addiction following consumption of MDMA as well as classifications of various substances under regulatory bodies. 

Finally, Dr Holland highlights the ‘alpha bias’ in current clinical research as expressed through her book ‘moody bitches’ and indicates the implications this could have.

Moody Bitches Book

Good Chemistry book

Maps 

Mdma

Mescaline

PCP

LSD

Cannabis

Fentanyl

Benzodiazapines

Ketamine

Psilocybin

Psilocybin psychotherapy

Schizophrenia

Anxiety

PTSD

Eating Disorders

Rosalind Watts

Norman Ohler

Telehealth Ketamine Study

Become a Drug Science Community Member

★ Support this podcast ★

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features